Steven Cohen's position in Design Therapeutics is currently worth $29.9M. That's 0.05% of their equity portfolio (401st largest holding). The investor owns 4.36% of the outstanding Design Therapeutics stock. The first Design Therapeutics trade was made in Q1 2023. Since then Steven Cohen bought shares six more times and sold shares on six occasions. The stake costed the investor $15.6M, netting the investor a gain of 92% so far.